Bromide

Bromide

SCHEMBL534887

Br.CN(C)Cc1ccccc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2B known ✓ P18089 1/20 0.50
ADRA2C known ✓ P18825 1/20 0.50
SLC6A2 known ✓ P23975 1/20 0.50
SLC6A4 known ✓ P31645 1/20 0.50
ADRA1A known ✓ P35348 1/20 0.50
SLC6A3 known ✓ Q01959 1/20 0.50
SIGMAR1 known ✓ Q99720 1/20 0.47
TSHR P16473 3/20 0.94
ALDH1A1 P00352 2/20 0.94
TAAR1 Q96RJ0 2/20 0.70
AOC3 Q16853 1/20 0.61
HRH3 Q9Y5N1 1/20 0.59
CARM1 Q86X55 1/20 0.52
PRMT6 Q96LA8 1/20 0.52
PRMT8 Q9NR22 1/20 0.52
CHRNB2 P17787 1/20 0.52
CHRNA4 P43681 1/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
LMNA P02545 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL414531 1.00 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Bromide SCHEMBL414532 1.00 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Benzene SCHEMBL27653708 1.00 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL15900 0.97 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL27766437 0.97 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL24735547 0.97 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL5014268 0.97 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
Ammonia Solution, Strong SCHEMBL4071832 0.94 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Iodide SCHEMBL6672021 0.94 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3
Hydrochloric Acid SCHEMBL6391891 0.94 TSHR (0.94) TSHRALDH1A1TAAR1AOC3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4721564-A1 COMPOSITIONS AND METHODS FOR DISINFECTING VEHICLES AND CARGO USED FOR TRANSPORTING ANIMALS Sani-Marc Inc. (CA) 2026-04-08 EP claimed
EP-4419619-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD Entegris, Inc. (US) 2024-08-28 EP claimed
CN-118234830-A Selective wet etching composition and method 恩特格里斯公司 2024-06-21 CN claimed
CN-117159459-A Low-concentration benzalkonium bromide sterile solution, and preparation method and detection method thereof 佑护(杭州)医疗科技有限公司 2023-12-05 CN claimed
CN-113150697-B Polishing solution for monocrystalline silicon piece surface polishing and preparation method thereof 广州凌玮科技股份有限公司 2023-08-22 CN claimed
CN-116583261-A Method for combating microorganisms using menthol derivatives 西姆莱斯股份公司 2023-08-11 CN claimed
CN-116120396-A Polypeptide and application thereof in preparation of preservative 华南协同创新研究院 2023-05-16 CN claimed
WO-2023069409-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD ENTEGRIS, INC. (US) 2023-04-27 WO claimed
US-20230121639-A1 SELECTIVE WET ETCH COMPOSITION AND METHOD ENTEGRIS, INC. 2023-04-20 US claimed
CN-114177341-B Preparation method of antibacterial medical foam dressing 常州美杰医疗用品有限公司 2023-01-31 CN claimed
EP-1511467-A1 NANOPARTICULATE POLYCOSANOL FORMULATIONS AND NOVEL POLYCOSANOL COMBINATIONS Elan Pharma International Limited (IE) 2005-03-09 EP claimed
EP-1511468-A1 NANOPARTICULATE STEROL FORMULATIONS AND STEROL COMBINATIONS Elan Pharma International Limited (IE) 2005-03-09 EP claimed
EP-1503737-A1 NANOPARTICULATE NYSTATIN FORMULATIONS Elan Pharma International Limited (IE) 2005-02-09 EP claimed
EP-1490030-A1 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS Elan Pharma International Limited (IE) 2004-12-29 EP claimed
WO-2003103640-A1 NANOPARTICULATE FORMULATIONS COMPRISING HMG COA REDUCTASE INHIBITOR DERIVATIVES (“STATINS”), NOVEL COMBINATIONS THEREOF AS WELL AS MANUFACTURING OF THESE PHARMACEUTICAL COMPOSITIONS ELAN PHARMA INTERNATIONAL, LTD (IE) 2003-12-18 WO claimed
WO-2003103632-A1 NANOPARTICULATE POLYCOSANOL FORMULATIONS AND NOVEL POLYCOSANOL COMBINATIONS ELAN PHARMA INTERNATIONAL, LTD. (IE) 2003-12-18 WO claimed
WO-2003103633-A1 NANOPARTICULATE STEROL FORMULATIONS AND STEROL COMBINATIONS ELAN PHARMA INTERNATIONAL, LTD. (IE) 2003-12-18 WO claimed
WO-2003094894-A1 NANOPARTICULATE NYSTATIN FORMULATIONS ELAN PHARMA INTERNATIONAL LTD. (IE) 2003-11-20 WO claimed
WO-2003080027-A1 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS ELAN PHARMA INTERNATIONAL, LTD. (IE) 2003-10-02 WO claimed
US-4117013-A AMINES, QUATERNARY AMMONIUM COMPOUNDS, OLEFIN EPOXIDES, HYDROXYQUI(OLINES, AMINE PHENOXIDES, GLYCIDYL HALIDES AND ETHERS UNITED TECHNOLOGIES CORPORATION (US) 1978-09-26 US claimed